Annual CFI
$24.76 M
+$30.73 M+514.19%
31 December 2023
Summary:
Trinity Biotech annual cash flow from investing activities is currently $24.76 million, with the most recent change of +$30.73 million (+514.19%) on 31 December 2023. During the last 3 years, it has risen by +$34.95 million (+342.75%). TRIB annual CFI is now -56.48% below its all-time high of $56.88 million, reached on 31 December 2010.TRIB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$3.10 M
+$66.00 K+2.08%
30 September 2024
Summary:
Trinity Biotech quarterly cash flow from investing activities is currently -$3.10 million, with the most recent change of +$66.00 thousand (+2.08%) on 30 September 2024. Over the past year, it has dropped by -$2.21 million (-250.00%). TRIB quarterly CFI is now -104.74% below its all-time high of $65.41 million, reached on 30 June 2010.TRIB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$21.12 M
-$2.21 M-11.72%
30 September 2024
Summary:
Trinity Biotech TTM cash flow from investing activities is currently -$21.12 million, with the most recent change of -$2.21 million (-11.72%) on 30 September 2024. Over the past year, it has dropped by -$45.63 million (-186.18%). TRIB TTM CFI is now -136.91% below its all-time high of $57.22 million, reached on 30 September 2010.TRIB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRIB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +514.2% | -250.0% | -186.2% |
| 3 y3 years | +342.8% | -58.3% | -245.1% |
| 5 y5 years | +242.3% | +48.7% | -21.5% |
TRIB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +342.8% | -111.1% | +77.8% | -185.3% | at low |
| 5 y | 5 years | at high | +242.3% | -111.1% | +77.8% | -185.3% | at low |
| alltime | all time | -56.5% | +139.1% | -104.7% | +92.8% | -136.9% | +65.6% |
Trinity Biotech Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.10 M(-2.1%) | -$21.12 M(+11.7%) |
| June 2024 | - | -$3.17 M(-77.3%) | -$18.91 M(-256.0%) |
| Mar 2024 | - | -$13.96 M(+1467.1%) | $12.12 M(-51.0%) |
| Dec 2023 | $24.76 M(-514.2%) | -$891.00 K(+0.6%) | $24.76 M(+1.0%) |
| Sept 2023 | - | -$886.00 K(-103.2%) | $24.51 M(+1.8%) |
| June 2023 | - | $27.86 M(-2196.5%) | $24.07 M(-530.5%) |
| Mar 2023 | - | -$1.33 M(+16.9%) | -$5.59 M(-6.5%) |
| Dec 2022 | -$5.98 M(-31.2%) | -$1.14 M(-14.1%) | -$5.98 M(-18.3%) |
| Sept 2022 | - | -$1.32 M(-26.5%) | -$7.32 M(-8.0%) |
| June 2022 | - | -$1.80 M(+5.0%) | -$7.95 M(+5.9%) |
| Mar 2022 | - | -$1.72 M(-30.7%) | -$7.51 M(-13.6%) |
| Dec 2021 | -$8.69 M(-14.8%) | -$2.48 M(+26.3%) | -$8.69 M(+42.0%) |
| Sept 2021 | - | -$1.96 M(+44.0%) | -$6.12 M(-10.7%) |
| June 2021 | - | -$1.36 M(-53.1%) | -$6.85 M(-33.7%) |
| Mar 2021 | - | -$2.90 M(-3149.5%) | -$10.34 M(+1.4%) |
| Dec 2020 | -$10.20 M(-14.0%) | $95.00 K(-103.5%) | -$10.20 M(+3.0%) |
| Sept 2020 | - | -$2.69 M(-44.5%) | -$9.90 M(-25.3%) |
| June 2020 | - | -$4.85 M(+75.8%) | -$13.26 M(+15.4%) |
| Mar 2020 | - | -$2.76 M(-806.7%) | -$11.49 M(-3.0%) |
| Dec 2019 | -$11.85 M(-31.8%) | $390.00 K(-106.4%) | -$11.85 M(-31.8%) |
| Sept 2019 | - | -$6.05 M(+96.3%) | -$17.39 M(-26.3%) |
| June 2019 | - | -$3.08 M(-1.1%) | -$23.59 M(+43.4%) |
| Mar 2019 | - | -$3.11 M(-39.5%) | -$16.44 M(-5.4%) |
| Dec 2018 | -$17.39 M(+7.5%) | -$5.14 M(-58.0%) | -$17.39 M(+3.8%) |
| Sept 2018 | - | -$12.25 M(-401.6%) | -$16.76 M(+103.4%) |
| June 2018 | - | $4.06 M(-200.0%) | -$8.24 M(-46.8%) |
| Mar 2018 | - | -$4.06 M(-9.9%) | -$15.48 M(-4.3%) |
| Dec 2017 | -$16.18 M(-26.0%) | -$4.51 M(+21.0%) | -$16.18 M(+4.7%) |
| Sept 2017 | - | -$3.73 M(+17.0%) | -$15.45 M(-10.6%) |
| June 2017 | - | -$3.19 M(-33.0%) | -$17.28 M(-18.5%) |
| Mar 2017 | - | -$4.76 M(+25.8%) | -$21.20 M(-3.1%) |
| Dec 2016 | -$21.88 M(-21.0%) | -$3.78 M(-31.9%) | -$21.88 M(-27.5%) |
| Sept 2016 | - | -$5.55 M(-21.8%) | -$30.17 M(+8.6%) |
| June 2016 | - | -$7.11 M(+30.9%) | -$27.79 M(-0.4%) |
| Mar 2016 | - | -$5.43 M(-55.0%) | -$27.90 M(+0.7%) |
| Dec 2015 | -$27.70 M(-0.2%) | -$12.07 M(+280.1%) | -$27.70 M(-0.7%) |
| Sept 2015 | - | -$3.18 M(-56.0%) | -$27.88 M(-10.3%) |
| June 2015 | - | -$7.22 M(+38.2%) | -$31.08 M(+11.3%) |
| Mar 2015 | - | -$5.22 M(-57.4%) | -$27.94 M(+0.7%) |
| Dec 2014 | -$27.76 M | -$12.26 M(+92.1%) | -$27.76 M(+15.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | -$6.38 M(+56.6%) | -$24.00 M(-60.3%) |
| June 2014 | - | -$4.08 M(-19.2%) | -$60.38 M(-1.5%) |
| Mar 2014 | - | -$5.04 M(-40.7%) | -$61.33 M(+0.2%) |
| Dec 2013 | -$61.19 M(+514.4%) | -$8.50 M(-80.1%) | -$61.19 M(+3.3%) |
| Sept 2013 | - | -$42.77 M(+752.1%) | -$59.26 M(+195.9%) |
| June 2013 | - | -$5.02 M(+2.2%) | -$20.02 M(+206.8%) |
| Mar 2013 | - | -$4.91 M(-25.3%) | -$6.53 M(-34.5%) |
| Dec 2012 | -$9.96 M(+7561.5%) | -$6.57 M(+86.2%) | -$9.96 M(+49.3%) |
| Sept 2012 | - | -$3.53 M(-141.6%) | -$6.67 M(+20.3%) |
| June 2012 | - | $8.48 M(-201.6%) | -$5.54 M(+3.3%) |
| Mar 2012 | - | -$8.34 M(+154.5%) | -$5.37 M(+4030.0%) |
| Dec 2011 | -$130.00 K(-100.2%) | -$3.28 M(+36.5%) | -$130.00 K(-91.5%) |
| Sept 2011 | - | -$2.40 M(-127.7%) | -$1.53 M(+137.3%) |
| June 2011 | - | $8.66 M(-378.8%) | -$646.00 K(-101.2%) |
| Mar 2011 | - | -$3.10 M(-33.7%) | $56.10 M(-1.4%) |
| Dec 2010 | $56.88 M(-650.4%) | -$4.68 M(+209.0%) | $56.88 M(-0.6%) |
| Sept 2010 | - | -$1.51 M(-102.3%) | $57.22 M(+0.1%) |
| June 2010 | - | $65.41 M(-2914.4%) | $57.13 M(-662.5%) |
| Mar 2010 | - | -$2.32 M(-46.6%) | -$10.16 M(-1.7%) |
| Dec 2009 | -$10.34 M(-29.6%) | -$4.35 M(+171.8%) | -$10.34 M(+72.6%) |
| Sept 2009 | - | -$1.60 M(-15.2%) | -$5.99 M(+36.5%) |
| June 2009 | - | -$1.89 M(-24.6%) | -$4.39 M(-50.9%) |
| Mar 2009 | - | -$2.50 M(-61.2%) | -$8.94 M(-1.3%) |
| Dec 2008 | -$14.69 M(+74.5%) | - | - |
| June 2008 | - | -$6.44 M(+145.5%) | -$9.06 M(+245.5%) |
| Mar 2008 | - | -$2.62 M | -$2.62 M |
| Dec 2007 | -$8.41 M(-86.7%) | - | - |
| Dec 2006 | -$63.27 M(+159.3%) | - | - |
| Dec 2005 | -$24.40 M(+56.1%) | - | - |
| Dec 2004 | -$15.63 M(+44.2%) | - | - |
| Dec 2003 | -$10.84 M(+46.6%) | - | - |
| Dec 2002 | -$7.39 M(-0.3%) | - | - |
| Dec 2001 | -$7.42 M(-52.6%) | - | - |
| Dec 2000 | -$15.64 M(+150.9%) | - | - |
| Dec 1999 | -$6.23 M(-37.7%) | - | - |
| Dec 1998 | -$10.00 M(+12.4%) | - | - |
| Dec 1997 | -$8.90 M(+196.7%) | - | - |
| Dec 1996 | -$3.00 M(-350.0%) | - | - |
| Dec 1995 | $1.20 M(>+9900.0%) | - | - |
| Dec 1994 | $0.00(-100.0%) | - | - |
| Feb 1994 | $100.00 K | - | - |
FAQ
- What is Trinity Biotech annual cash flow from investing activities?
- What is the all time high annual CFI for Trinity Biotech?
- What is Trinity Biotech annual CFI year-on-year change?
- What is Trinity Biotech quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Trinity Biotech?
- What is Trinity Biotech quarterly CFI year-on-year change?
- What is Trinity Biotech TTM cash flow from investing activities?
- What is the all time high TTM CFI for Trinity Biotech?
- What is Trinity Biotech TTM CFI year-on-year change?
What is Trinity Biotech annual cash flow from investing activities?
The current annual CFI of TRIB is $24.76 M
What is the all time high annual CFI for Trinity Biotech?
Trinity Biotech all-time high annual cash flow from investing activities is $56.88 M
What is Trinity Biotech annual CFI year-on-year change?
Over the past year, TRIB annual cash flow from investing activities has changed by +$30.73 M (+514.19%)
What is Trinity Biotech quarterly cash flow from investing activities?
The current quarterly CFI of TRIB is -$3.10 M
What is the all time high quarterly CFI for Trinity Biotech?
Trinity Biotech all-time high quarterly cash flow from investing activities is $65.41 M
What is Trinity Biotech quarterly CFI year-on-year change?
Over the past year, TRIB quarterly cash flow from investing activities has changed by -$2.21 M (-250.00%)
What is Trinity Biotech TTM cash flow from investing activities?
The current TTM CFI of TRIB is -$21.12 M
What is the all time high TTM CFI for Trinity Biotech?
Trinity Biotech all-time high TTM cash flow from investing activities is $57.22 M
What is Trinity Biotech TTM CFI year-on-year change?
Over the past year, TRIB TTM cash flow from investing activities has changed by -$45.63 M (-186.18%)